ELIE SAAB: Ready To Wear Spring Summer 2027 “A Fleur De Peau”

ELIE SAAB Spring-Summer 2027 brings cinematic femininity to Paris through fluid gowns, delicate lace and silhouettes shaped by timeless glamour.

Global Furniture Brand DEDON Adopts COREnergy’s Sunshine Plan

DEDON Manufacturing becomes COREnergy’s first Sunshine Plan customer through a two-year retail electricity supply agreement.

Distressed Denim Meets Brocade In Marques’Almeida’s Spring/Summer 2027

Marques’Almeida brings rawness and refinement into the same frame for Spring/Summer 2027, pairing sculptural proportions with the brand’s instinctively undone approach.

Pre-Order And Own The Latest iPhone 18 Pro And iPhone 18 Pro Max For As Low As PHP137 Per Day With Home Credit

Home Credit Philippines gives Filipinos more flexible ways to pre-order and own the latest iPhone 18 Pro models.

Global Coronavirus Cases Surpass 40M

The number of the COVID-19 cases in the world has surpassed 40 million on Monday.

Global Coronavirus Cases Surpass 40M

96
96

How do you feel about this story?

Express Your Reaction
Like
Love
Haha
Wow
Sad
Angry

The number of the coronavirus disease 2019 (Covid-19) cases in the world has surpassed 40 million early Monday, according to Johns Hopkins University data.

More than 1.11 million people have lost their lives around the world from Covid-19 so far.

The US still leads the world in the number of Covid-19 cases with over 8.15 million, while deaths are at almost 220,000.

In India, more than 7.55 million people contracted the virus with a death toll of over 114,600. Brazil has more than 5.22 million cases and a death toll exceeding 153,600.

China, the birthplace of Covid-19, has close to 91,000 cases with 4,739 deaths.

The UK’s Scientific Advisory Group for Emergencies said Sunday more than one coronavirus vaccine will be available at the beginning of 2021.

American pharmaceutical firm Pfizer said Friday it may know the effectiveness of its vaccine by the end of October, and it is planning to submit safety data on the final dose of the vaccine to the US Food and Drug Administration in the third week of November.

A vaccine candidate developed by the Beijing Institute of Biological Products, affiliated to the state-owned China National Pharmaceutical Group (Sinopharm), elicited antibody response in recipients, according to a study published Thursday in the Lancet Infectious Diseases journal.

Meanwhile, Russian President Vladimir Putin said Wednesday that a second coronavirus vaccine, EpiVakKorona, has been granted regulatory approval.

There are more than 170 vaccines around the world that are candidates for Covid-19 and tracked by the World Health Organization, but none has been approved for general use yet. (PNA)